Daratumumab for refractory immune-mediated thrombotic thrombocytopenic purpura.

Autor: Aggarwal A; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., White D; Department of Clinical Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Pavord S; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Thomas W; Department of Clinical Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Desborough MJR; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Jazyk: angličtina
Zdroj: British journal of haematology [Br J Haematol] 2023 Jul; Vol. 202 (2), pp. 429-433. Date of Electronic Publication: 2023 May 14.
DOI: 10.1111/bjh.18854
Databáze: MEDLINE